Entero Healthcare Solutions Ltd.

NSE: ENTERO

BSE: 544122

Sector: Consumer Services

Industry Group: Retailing

Industry: Pharmacy Retail

1,172.00-38.1 (-3.15%)

8 Jul, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Entero Healthcare Solutions Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M PR	12M PR	12M PR	12M AR	12M AR	12M PRESS
Total Revenue	1,350	1,780	2,522	3,300	3,922	5,096	6,591
Cost of Operating Revenue	1,253	1,658	2,336	3,060	3,601	4,647	5,954
Gross Profit	97	122	186	240	321	448	637
Gross Margin	7.2	6.9	7.4	7.3	8.2	8.8	9.7
Total Operating Expenses	1,338	1,774	2,517	3,260	3,835	4,955	6,369
Operating Profit	12	5	5	40	87	141	223
Operating Margin	0.9	0.3	0.2	1.2	2.2	2.8	3.4
Financing Income/(Expense) - Net	-9	-17	-25	-45	-53	-4	-54
Profit before Taxes	4	-11	-20	-4	36	139	179
Income Taxes	3	5	10	7	-4	31	33
Profit after Tax	1	-16	-30	-12	39	95	115
PAT Margin	0.1	-0.9	-1.2	-0.4	1.0	1.9	1.7
EPS - Basic - ex Extraordinary Items	0.22	-3.57	-6.88	-2.66	10.81	21.80	26.44
EPS - Diluted - ex Extraordinary Items	0.22	-3.57	-6.88	-2.66	10.81	21.76	26.40
EBIT	12	5	5	40	87	141	223
EBITDA	24	22	24	64	112	172	266
EBITDA Margin	1.7	1.2	1.0	1.9	2.9	3.4	4.0

Balance Sheet

Abridged

Understanding Balance Sheet

Entero Healthcare Solutions Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	PR	PR	PR	AR	AR	PRESS
Total Current Assets	552	633	851	1,023	2,011	2,076	2,508
Long-Term Investments	-	-	-	-	-	-	49
Property Plant & Equipment - Net	97	97	108	97	93	132	200
Total Non-Current Assets	197	201	275	286	334	627	1,092
Total Assets	749	834	1,126	1,309	2,345	2,703	3,600
Total Current Liabilities	269	289	462	624	602	845	1,588
Long Term Debt	52	53	95	81	95	67	205
Total Non-Current Liabilities	56	58	101	87	102	87	260
Total Liabilities	325	347	563	711	704	932	1,848
Total Shareholders' Equity	423	485	561	595	1,638	1,724	1,689
Minority Interest	2	2	2	3	3	46	64
Total Equity	424	487	563	598	1,641	1,770	1,753
Total Liabilities & Equity	749	834	1,126	1,309	2,345	2,703	3,600

Cash Flow

Abridged

Understanding Cash Flow Statement

Entero Healthcare Solutions Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M PR	12M PR	12M PR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	22	8	-17	10	52	141	206
Working Capital - Increase/(Decrease)	-69	-94	-44	-100	-146	-222	-136
Net CF from Operating Activities	-47	-87	-61	-90	-93	-80	69
Capital Expenditures - Net	45	10	10	6	5	10	67
Net CF from Investing Activities	-206	-33	-165	-53	-715	182	-317
Stock - Issuance/(Retirement) - Net	179	78	106	45	1,051	1	0
Debt - LT & ST - Issuance/(Retirement) - Total	50	31	135	77	-115	3	164
Net Cash Flow from Financing Activities	230	109	240	122	929	-32	164
Free Cash Flow to Equity	-42	-65	64	-19	-213	-88	166
Free Operating CF net dividend	-92	-96	-71	-96	-99	-92	2
Free Operating CF	-92	-96	-71	-96	-99	-92	2

Business Segment Analysis

FY End:

Mar 25

Entero Healthcare Solutions Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharmaceuticals (100.0%)₹ 11.31 Cr

Revenue / Sales

Pharmaceuticals (100.0%)₹ 5,095.78 Cr

Assets

Pharmaceuticals (100.0%)₹ 2,702.52 Cr

Operating Income

Pharmaceuticals (100.0%)₹ 141.01 Cr

Regional Segment Analysis

FY End:

Mar 25

Entero Healthcare Solutions Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (100.0%)₹ 5,095.78 Cr

Assets

India (100.0%)₹ 2,702.52 Cr

Historical Segment Analysis

Track how Entero Healthcare Solutions Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Pharmaceuticals	45	10	10	6	5	11

Frequently Asked Questions

What is the revenue of Entero Healthcare Solutions Ltd.?

The latest trailing twelve month revenue of Entero Healthcare Solutions Ltd. is ₹ 6,591.21 Cr, reflecting a 1-year growth of 29.35% and a 3-year CAGR of 25.93%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Entero Healthcare Solutions Ltd.?

The latest trailing twelve month net profit (PAT) of Entero Healthcare Solutions Ltd. is ₹ 115.04 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Entero Healthcare Solutions Ltd.?

The trailing twelve month EBITDA of Entero Healthcare Solutions Ltd. is approximately ₹ 222.66 Cr (based on an operating margin of 3.38%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Entero Healthcare Solutions Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Entero Healthcare Solutions Ltd. is 26.40. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Entero Healthcare Solutions Ltd.?

The debt-to-equity ratio of Entero Healthcare Solutions Ltd. stands at 0.40. The interest coverage ratio is 4.09x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Entero Healthcare Solutions Ltd.?

The estimated book value per share of Entero Healthcare Solutions Ltd. is 387.98 (derived from a P/B ratio of 3.02 and market price of ₹ 1,172.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Entero Healthcare Solutions Ltd.?

The trailing twelve month operating cash flow of Entero Healthcare Solutions Ltd. is ₹ 69.32 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Entero Healthcare Solutions Ltd. report consolidated or standalone financials?

Entero Healthcare Solutions Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.